Bone Marrow Transplant (BMT) has become a life-saving treatment for patients with blood disorders and certain cancers. With India emerging as a global hub for affordable and advanced medical treatments, bone marrow transplants in the country are performed by world-renowned specialists using the latest techniques. Dr. Rahul Bhargava, one of India's leading hematologists and transplant experts, has played a pivotal role in making BMT accessible and successful for both Indian and international patients.
What is a Bone Marrow Transplant?
A Bone Marrow Transplant (BMT) is a specialized medical treatment used to replace damaged or diseased bone marrow with healthy blood-forming stem cells. Bone marrow, found in the soft center of bones, is responsible for producing red blood cells, white blood cells, and platelets. When diseases like leukemia, lymphoma, myeloma, or bone marrow failure syndromes affect this process, a transplant can help regenerate the marrow and restore normal blood cell production.
A bone marrow transplant is typically recommended for patients whose bone marrow is not functioning properly or has been damaged by disease or aggressive treatment. This procedure is often a last resort when conventional therapies are no longer effective or when a cure is only possible through transplantation. Individuals who may require a BMT include:
The decision to proceed with a transplant is made after evaluating several factors, including age, overall health, disease progression, and availability of a compatible donor.
There are three primary types of bone marrow transplants, each suited to specific medical needs and patient conditions:
In this type, the patient’s own healthy stem cells are collected and stored before undergoing high-dose chemotherapy or radiation. After the treatment eliminates diseased or cancerous cells, the stored stem cells are reinfused into the patient’s body to help rebuild the bone marrow. This is often used for cancers like multiple myeloma and certain lymphomas. It minimizes the risk of rejection or graft-versus-host disease (GVHD).
This involves the use of stem cells from a genetically matched donor, usually a sibling or close family member. It is used when the patient’s own stem cells are not healthy enough, as seen in conditions like leukemia or severe aplastic anemia. A key benefit is that the donor immune system may also help destroy remaining cancer cells, known as the graft-versus-leukemia effect. However, there is a higher risk of GVHD, which is managed with immunosuppressants.
For patients without a fully matched donor, haploidentical transplants use stem cells from a half-matched relative, such as a parent or child. Alternatively, unrelated donors may be sourced from international registries. These transplants are more complex and require careful monitoring, but advances in medical protocols have made them increasingly successful and accessible, especially in India.
Each transplant type is chosen based on the patient's diagnosis, urgency, donor availability, and overall health.
The Bone Marrow Transplant (BMT) process is a structured, multi-stage procedure that requires close coordination between specialists and the patient. Here is a breakdown of each step:
Before the transplant begins, the patient undergoes a thorough evaluation, which includes:
This helps the medical team determine the patient’s overall fitness and suitability for the transplant.
This involves administering high-dose chemotherapy (and sometimes radiation) to:
Conditioning typically lasts 5–7 days and prepares the body to receive the new stem cells.
Once conditioning is complete, healthy stem cells are infused into the patient's bloodstream through a central line (similar to a blood transfusion). The infusion is painless and takes 30 minutes to several hours, depending on the volume of cells.
This is the phase where the transplanted stem cells begin to settle in the bone marrow and start producing new blood cells. Engraftment usually occurs within 10–21 days. During this time, patients are monitored closely for:
After engraftment, the patient requires continuous care, which includes:
Recovery can take several weeks to months, and patients are advised to avoid crowded places and follow hygiene protocols strictly during this time.
India is recognized globally for offering high-quality bone marrow transplants at a fraction of the cost compared to Western nations. The affordability is due to efficient healthcare delivery, lower hospital infrastructure costs, and skilled medical professionals available at competitive pricing.
Compared to countries like the US or UK where similar procedures can cost $100,000–$250,000 USD, India offers a cost-effective solution with high success rates, attracting patients from the Middle East, Africa, Europe, and Southeast Asia. India offers highly competitive pricing for BMT without compromising on quality.
India has gained a strong reputation for bone marrow transplant procedures, offering a combination of cost-effectiveness and advanced medical expertise. Here’s why many international patients choose India:
These combined strengths make India one of the most reliable and preferred medical tourism destinations for bone marrow transplants.
Some of the best centers offering BMT include:
Dr. Rahul Bhargava is widely regarded as one of India’s top hematologists and bone marrow transplant (BMT) specialists. With more than 1,500 successful transplants to his name, he has transformed the landscape of hematological care in India. He currently serves as the Director of Hematology and Bone Marrow Transplant at Fortis Memorial Research Institute, Gurugram.
Dr. Bhargava is not just known for his medical expertise, but also for his compassionate and holistic approach to patient care. His commitment to affordable, ethical, and personalized treatment has earned him the trust of patients across India and abroad.
To consult with Dr. Rahul Bhargava or plan your bone marrow transplant in India, contact Fortis Memorial Research Institute, Gurugram. World-class care is just one call away.